Your session is about to expire
← Back to Search
Low-Dose High-Resolution Breast CT for Breast Cancer (LowerDoseBCT Trial)
N/A
Waitlist Available
Led By Srinivasan Vedantham, PhD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients who satisfy University of Arizona (UA) - Banner University Medical Center (BUMC), Department of Medical Imaging policy for administration of iodinated contrast media for computed tomography (CT) imaging, which may include a blood draw for renal function assessment.
Patients who were asymptomatic and 40 years of age or older (typical screening age range) at the time of the screening exam that prompted the recall
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
LowerDoseBCT Trial Summary
This trial is testing a new breast imaging technique to see if it can better distinguish between cancerous and non-cancerous growths.
Who is the study for?
This trial is for women over 40 who've had a suspicious breast screening result (BI-RADS category 4 or 5) and no known allergies to iodinated contrast media. It's not for those unable to consent, with physical limitations, over the BCT table weight limit of 440 lbs, prior thorax radiation treatment, impaired kidney function, history of excessive diagnostic x-rays, men, under age 40, prisoners or pregnant/breastfeeding women.Check my eligibility
What is being tested?
The study tests if a new type of breast imaging called dedicated breast CT (BCT) can better reveal small structures in the breast tissue and improve accuracy in diagnosing breast cancer compared to traditional methods like mammography.See study design
What are the potential side effects?
Potential side effects may include reactions to iodinated contrast media used during BCT such as nausea or itching. There might also be discomfort from lying prone on the exam table and exposure to additional radiation.
LowerDoseBCT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I meet the requirements for CT scans with contrast at UA-BUMC.
Select...
I was 40 or older and had no symptoms when my screening led to further tests.
LowerDoseBCT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Diagnostic accuracy
Secondary outcome measures
Contrast enhancement quantification
LowerDoseBCT Trial Design
1Treatment groups
Experimental Treatment
Group I: Dedicated breast computed tomography (BCT)Experimental Treatment1 Intervention
All subjects will undergo bilateral breast CT (BCT) imaging exam.
Find a Location
Who is running the clinical trial?
University of ArizonaLead Sponsor
512 Previous Clinical Trials
147,633 Total Patients Enrolled
22 Trials studying Breast Cancer
1,964 Patients Enrolled for Breast Cancer
National Institutes of Health (NIH)NIH
2,682 Previous Clinical Trials
6,930,198 Total Patients Enrolled
49 Trials studying Breast Cancer
110,185 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,621 Previous Clinical Trials
40,926,822 Total Patients Enrolled
938 Trials studying Breast Cancer
1,542,743 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been in a breast study before that involved extra radiation.I am allergic to contrast dye used in medical imaging.My kidney function is low, with a GFR under 30 mL/min.I have had radiation therapy to my chest area for cancer or other conditions.I meet the requirements for CT scans with contrast at UA-BUMC.I was 40 or older and had no symptoms when my screening led to further tests.I am a woman under 40 years old.I have had many X-rays for conditions like tuberculosis or severe scoliosis.I am male.I have physical issues that prevent me from lying face down comfortably.I am a woman who cannot give consent by myself.
Research Study Groups:
This trial has the following groups:- Group 1: Dedicated breast computed tomography (BCT)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is it currently possible to enroll in this research effort?
"According to the information hosted on clinicaltrials.gov, this particular medical trial is not accepting patients at present; it was initially posted on December 1st 2022 and last updated November 4th 2022. Nonetheless, there are many other trials actively recruiting individuals - 1403 in total!"
Answered by AI
Share this study with friends
Copy Link
Messenger